Agile Therapeutics Security Rating

Agile Therapeutics is the pharmaceutical company developing contraceptive healthcare products for women. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive patch.In addition to Twirla, Agile is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of the Company's product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.